Global Invasive Fungal Infection Market Growth (Status and Outlook) 2024-2030

2024

Global Invasive Fungal Infection Market Growth (Status and Outlook) 2024-2030

Name: Global Invasive Fungal Infection Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95001361
Price: 3450 USD
Availability: InStock
Rating: 5 (13.75 reviews)

The global invasive fungal infection market is valued at US$ 10.14 billion in 2024 and is expected to grow to US$ 13.85 billion by 2030, driven by increasing fungal infections in i

Bonafide Trust
22-10-2024
Pages : 131
Figures : 79
Tables : 130
Region : Global
Category : Lifescience & Healthcare
Pharmaceutical

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global Invasive Fungal Infection market was valued at USD 10,140 million in 2024 and is forecast to reach USD 13,850 million by 2030, growing at a compound annual growth rate (CAGR) of 4.6% during the review period. Invasive fungal infections, which occur when fungi invade human tissues and blood, leading to tissue damage, organ dysfunction, and inflammation, are becoming an increasing global concern. These infections are particularly prevalent among immunocompromised patients, including those with HIV/AIDS, cancer, and organ transplant recipients. The rising incidence of these infections, along with the growing demand for effective diagnostic and treatment solutions, is expected to drive the market’s growth. This market encompasses a range of products, including advanced diagnostic tools such as PCR-based tests and molecular diagnostics, and treatment options, such as antifungal drugs and therapies. As the healthcare sector places greater emphasis on identifying and treating fungal infections early, the market is expected to expand steadily. However, despite these positive growth factors, the industry faces several challenges that could potentially limit market potential. High treatment costs, particularly for advanced antifungal therapies, the complexity and time-consuming nature of fungal infection diagnoses, and increasing resistance to antifungal drugs are some of the significant barriers. Consequently, companies operating in the market will need to focus on cost-effective treatment solutions, faster diagnostic technologies, and new product innovations to overcome these challenges and ensure widespread adoption of invasive fungal infection treatments.

The global pharmaceutical market, a key contributor to the invasive fungal infection treatment sector, is expected to grow steadily in the coming years. Valued at USD 1.475 trillion in 2022, the pharmaceutical industry is projected to maintain its growth momentum, driven by increasing demand for healthcare, advancements in drug development, and the rise of chronic diseases worldwide. The biologics segment alone was expected to reach USD 381 billion in 2022, illustrating the sector’s shift towards biologically-derived medicines. This growth is fueled by advancements in biotechnology, which are helping to develop more effective and personalized treatment options, including for invasive fungal infections. However, the pharmaceutical industry faces significant challenges that may hinder its growth, including rising research and development costs, patent expirations for key drugs, and stringent regulatory requirements that slow the approval process. Pharmaceutical companies involved in the invasive fungal infection market must continuously invest in research to discover novel treatments for fungal infections. In particular, drug-resistant fungal strains are becoming increasingly common, making the need for new antifungal agents more urgent. The COVID-19 pandemic also highlighted the vulnerabilities of the healthcare supply chain and the urgent need for pharmaceutical companies to develop more agile systems for vaccine and drug production. Furthermore, it emphasized the importance of swift responses to emerging public health crises, such as fungal outbreaks. In this context, companies in the pharmaceutical industry must be prepared to innovate, streamline their processes, and collaborate with governmental and private institutions to overcome the existing barriers and expand the availability of life-saving treatments for invasive fungal infections.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

Technological advancements play a crucial role in shaping the future of the invasive fungal infection market. One of the most promising developments in this field is the advancement of diagnostic technologies. Traditional diagnostic methods for fungal infections, such as culture tests, can take several days to yield results, which often delays treatment and worsens patient outcomes. In contrast, newer diagnostic methods, such as PCR-based tests, next-generation sequencing, and antigen-based rapid tests, provide faster and more accurate results, enabling healthcare professionals to initiate appropriate treatment promptly. The growing reliance on these innovative diagnostic tools will contribute significantly to market growth, as more healthcare providers adopt them to improve patient care. On the treatment side, advancements in antifungal therapies are also critical. Drug development for invasive fungal infections is increasingly focusing on overcoming challenges such as antifungal resistance and the need for more targeted therapies. The rise of drug-resistant fungal strains, driven by the overuse and misuse of antifungal medications, has made it necessary to develop new classes of antifungal agents. In response to this, the pharmaceutical industry is focusing on discovering novel antifungal compounds that can target resistant strains more effectively. Additionally, research into novel drug delivery systems, such as nanoparticle-based formulations, could improve the bioavailability and efficacy of antifungal drugs. Another important trend is the integration of artificial intelligence (AI) and machine learning (ML) into the development of both diagnostic tools and treatment strategies. AI and ML algorithms can analyze large datasets to identify potential biomarkers for early detection, predict disease progression, and optimize treatment regimens for individual patients. As these technologies evolve, they have the potential to revolutionize the invasive fungal infection treatment landscape, making diagnosis and treatment more personalized and efficient.

Government policies and incentives are playing an increasingly important role in driving the growth of the invasive fungal infection market. Many governments are recognizing the rising burden of infectious diseases, including invasive fungal infections, and are implementing policies to encourage innovation in diagnostics and treatments. These policies may include subsidies, tax incentives, and grants to support research and development activities within the pharmaceutical industry. In particular, governments are offering incentives to companies that develop treatments for neglected or emerging infections, including invasive fungal infections, which are often underfunded compared to other medical conditions. Regulatory frameworks that expedite the approval of antifungal drugs are also being introduced to speed up the availability of critical treatments to patients in need. In addition, governments worldwide are investing in healthcare infrastructure and public health campaigns to raise awareness about invasive fungal infections. These campaigns aim to educate the public and healthcare providers about the symptoms of these infections and the importance of early diagnosis and treatment. Such efforts will likely increase demand for diagnostic tests and therapies, further driving the market’s growth. At the same time, governments are working closely with global organizations, such as the World Health Organization (WHO), to ensure equitable access to fungal infection treatments, especially in low- and middle-income countries, where healthcare access may be limited. Through these efforts, government policies are helping create a more favorable environment for the invasive fungal infection market, enabling faster development and distribution of treatments and improving access to care for vulnerable populations.

Environmental sustainability is becoming an increasingly important consideration in the development of invasive fungal infection treatments and diagnostics. As the market grows, stakeholders are under increasing pressure to adopt environmentally friendly practices throughout the lifecycle of their products. The production of pharmaceutical drugs, including antifungal treatments, is associated with significant environmental impacts, such as energy consumption, waste generation, and the release of harmful chemicals into the environment. Companies are therefore exploring ways to reduce their environmental footprint by implementing sustainable manufacturing practices, utilizing renewable energy sources, and adopting waste-reduction strategies. The use of green chemistry in drug development is another area of focus, as it can help reduce the use of toxic chemicals and solvents in the production process. Packaging is another key area where companies are making strides toward sustainability. As the use of single-use plastics in healthcare packaging contributes to environmental pollution, pharmaceutical companies are exploring biodegradable and recyclable packaging materials for antifungal drugs and diagnostic kits. In addition to these efforts, healthcare providers are also focusing on green hospital initiatives that aim to reduce the environmental impact of healthcare delivery. By investing in energy-efficient infrastructure, waste management systems, and eco-friendly materials, hospitals and clinics can reduce their overall environmental footprint while providing high-quality care to patients with invasive fungal infections. As sustainability becomes an increasingly important issue in the healthcare sector, stakeholders in the invasive fungal infection market must continue to develop and adopt practices that reduce their environmental impact while ensuring that patients have access to safe, effective, and affordable treatments.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

The competitive landscape of the invasive fungal infection market is characterized by a mix of established pharmaceutical companies and emerging biotech firms. Large multinational pharmaceutical companies, such as Pfizer, Merck, and Johnson & Johnson, are major players in the market, given their extensive resources and global reach. These companies are well-positioned to lead in the development of novel antifungal treatments and diagnostics, leveraging their strong R&D capabilities and established distribution networks. In addition, these players are actively involved in partnerships and collaborations with academic institutions, biotech firms, and government agencies to accelerate the development of new therapies. On the other hand, smaller biotech companies and specialized firms are making significant contributions to the market, particularly by focusing on niche segments, such as antifungal resistance and personalized treatment approaches. These emerging players often have more agility and flexibility to focus on innovative solutions that address unmet needs within the market. Partnerships between large pharmaceutical companies and smaller biotech firms are expected to increase, enabling both sides to combine their expertise and resources for faster product development. The competitive dynamics of the market are also influenced by pricing strategies, as the high cost of antifungal treatments can limit accessibility, particularly in low-income regions. Companies are therefore under increasing pressure to develop cost-effective solutions to make their treatments more widely available. As the market evolves, companies will need to focus on staying ahead of emerging trends, investing in innovative research, and adapting to changing consumer demands to maintain a competitive edge.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Invasive Fungal Infection Market Size 2019-2030
2.1.2 Invasive Fungal Infection Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Invasive Fungal Infection Segment by Type
2.2.1 Diagnosis
2.2.2 Treatment
2.3 Invasive Fungal Infection Market Size by Type
2.3.1 Invasive Fungal Infection Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Invasive Fungal Infection Market Size Market Share by Type (2019-2024)
2.4 Invasive Fungal Infection Segment by Application
2.4.1 Yeast-like Fungi
2.4.2 Filamentous Fungi
2.4.3 Other
2.5 Invasive Fungal Infection Market Size by Application
2.5.1 Invasive Fungal Infection Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Invasive Fungal Infection Market Size Market Share by Application (2019-2024)
3 Invasive Fungal Infection Market Size by Player
3.1 Invasive Fungal Infection Market Size Market Share by Players
3.1.1 Global Invasive Fungal Infection Revenue by Players (2019-2024)
3.1.2 Global Invasive Fungal Infection Revenue Market Share by Players (2019-2024)
3.2 Global Invasive Fungal Infection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Invasive Fungal Infection by Regions
4.1 Invasive Fungal Infection Market Size by Regions (2019-2024)
4.2 Americas Invasive Fungal Infection Market Size Growth (2019-2024)
4.3 APAC Invasive Fungal Infection Market Size Growth (2019-2024)
4.4 Europe Invasive Fungal Infection Market Size Growth (2019-2024)
4.5 Middle East & Africa Invasive Fungal Infection Market Size Growth (2019-2024)
5 Americas
5.1 Americas Invasive Fungal Infection Market Size by Country (2019-2024)
5.2 Americas Invasive Fungal Infection Market Size by Type (2019-2024)
5.3 Americas Invasive Fungal Infection Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Invasive Fungal Infection Market Size by Region (2019-2024)
6.2 APAC Invasive Fungal Infection Market Size by Type (2019-2024)
6.3 APAC Invasive Fungal Infection Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Invasive Fungal Infection by Country (2019-2024)
7.2 Europe Invasive Fungal Infection Market Size by Type (2019-2024)
7.3 Europe Invasive Fungal Infection Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Invasive Fungal Infection by Region (2019-2024)
8.2 Middle East & Africa Invasive Fungal Infection Market Size by Type (2019-2024)
8.3 Middle East & Africa Invasive Fungal Infection Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Invasive Fungal Infection Market Forecast
10.1 Global Invasive Fungal Infection Forecast by Regions (2025-2030)
10.1.1 Global Invasive Fungal Infection Forecast by Regions (2025-2030)
10.1.2 Americas Invasive Fungal Infection Forecast
10.1.3 APAC Invasive Fungal Infection Forecast
10.1.4 Europe Invasive Fungal Infection Forecast
10.1.5 Middle East & Africa Invasive Fungal Infection Forecast
10.2 Americas Invasive Fungal Infection Forecast by Country (2025-2030)
10.2.1 United States Invasive Fungal Infection Market Forecast
10.2.2 Canada Invasive Fungal Infection Market Forecast
10.2.3 Mexico Invasive Fungal Infection Market Forecast
10.2.4 Brazil Invasive Fungal Infection Market Forecast
10.3 APAC Invasive Fungal Infection Forecast by Region (2025-2030)
10.3.1 China Invasive Fungal Infection Market Forecast
10.3.2 Japan Invasive Fungal Infection Market Forecast
10.3.3 Korea Invasive Fungal Infection Market Forecast
10.3.4 Southeast Asia Invasive Fungal Infection Market Forecast
10.3.5 India Invasive Fungal Infection Market Forecast
10.3.6 Australia Invasive Fungal Infection Market Forecast
10.4 Europe Invasive Fungal Infection Forecast by Country (2025-2030)
10.4.1 Germany Invasive Fungal Infection Market Forecast
10.4.2 France Invasive Fungal Infection Market Forecast
10.4.3 UK Invasive Fungal Infection Market Forecast
10.4.4 Italy Invasive Fungal Infection Market Forecast
10.4.5 Russia Invasive Fungal Infection Market Forecast
10.5 Middle East & Africa Invasive Fungal Infection Forecast by Region (2025-2030)
10.5.1 Egypt Invasive Fungal Infection Market Forecast
10.5.2 South Africa Invasive Fungal Infection Market Forecast
10.5.3 Israel Invasive Fungal Infection Market Forecast
10.5.4 Turkey Invasive Fungal Infection Market Forecast
10.5.5 GCC Countries Invasive Fungal Infection Market Forecast
10.6 Global Invasive Fungal Infection Forecast by Type (2025-2030)
10.7 Global Invasive Fungal Infection Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Cidara Therapeutics
11.1.1 Cidara Therapeutics Company Information
11.1.2 Cidara Therapeutics Invasive Fungal Infection Product Offered
11.1.3 Cidara Therapeutics Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Cidara Therapeutics Main Business Overview
11.1.5 Cidara Therapeutics Latest Developments
11.2 Basilea Pharmaceutica
11.2.1 Basilea Pharmaceutica Company Information
11.2.2 Basilea Pharmaceutica Invasive Fungal Infection Product Offered
11.2.3 Basilea Pharmaceutica Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Basilea Pharmaceutica Main Business Overview
11.2.5 Basilea Pharmaceutica Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Invasive Fungal Infection Product Offered
11.3.3 Pfizer Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Invasive Fungal Infection Product Offered
11.4.3 GlaxoSmithKline Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Invasive Fungal Infection Product Offered
11.5.3 Bayer Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 Abbott
11.6.1 Abbott Company Information
11.6.2 Abbott Invasive Fungal Infection Product Offered
11.6.3 Abbott Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Abbott Main Business Overview
11.6.5 Abbott Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Invasive Fungal Infection Product Offered
11.7.3 Merck Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Astellas Pharma
11.8.1 Astellas Pharma Company Information
11.8.2 Astellas Pharma Invasive Fungal Infection Product Offered
11.8.3 Astellas Pharma Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Astellas Pharma Main Business Overview
11.8.5 Astellas Pharma Latest Developments
11.9 F2G
11.9.1 F2G Company Information
11.9.2 F2G Invasive Fungal Infection Product Offered
11.9.3 F2G Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 F2G Main Business Overview
11.9.5 F2G Latest Developments
11.10 Scynexis
11.10.1 Scynexis Company Information
11.10.2 Scynexis Invasive Fungal Infection Product Offered
11.10.3 Scynexis Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Scynexis Main Business Overview
11.10.5 Scynexis Latest Developments
11.11 Associates of Cape Cod
11.11.1 Associates of Cape Cod Company Information
11.11.2 Associates of Cape Cod Invasive Fungal Infection Product Offered
11.11.3 Associates of Cape Cod Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Associates of Cape Cod Main Business Overview
11.11.5 Associates of Cape Cod Latest Developments
11.12 BioRad
11.12.1 BioRad Company Information
11.12.2 BioRad Invasive Fungal Infection Product Offered
11.12.3 BioRad Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 BioRad Main Business Overview
11.12.5 BioRad Latest Developments
11.13 IMMY
11.13.1 IMMY Company Information
11.13.2 IMMY Invasive Fungal Infection Product Offered
11.13.3 IMMY Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 IMMY Main Business Overview
11.13.5 IMMY Latest Developments
11.14 Beijing Jinshanchuan
11.14.1 Beijing Jinshanchuan Company Information
11.14.2 Beijing Jinshanchuan Invasive Fungal Infection Product Offered
11.14.3 Beijing Jinshanchuan Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Beijing Jinshanchuan Main Business Overview
11.14.5 Beijing Jinshanchuan Latest Developments
11.15 Danna Biological
11.15.1 Danna Biological Company Information
11.15.2 Danna Biological Invasive Fungal Infection Product Offered
11.15.3 Danna Biological Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Danna Biological Main Business Overview
11.15.5 Danna Biological Latest Developments
11.16 Zhanjiang A and C Biological
11.16.1 Zhanjiang A and C Biological Company Information
11.16.2 Zhanjiang A and C Biological Invasive Fungal Infection Product Offered
11.16.3 Zhanjiang A and C Biological Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Zhanjiang A and C Biological Main Business Overview
11.16.5 Zhanjiang A and C Biological Latest Developments
12 Research Findings and Conclusion

Table 1. Invasive Fungal Infection Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Diagnosis
Table 3. Major Players of Treatment
Table 4. Invasive Fungal Infection Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Invasive Fungal Infection Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Invasive Fungal Infection Market Size Market Share by Type (2019-2024)
Table 7. Invasive Fungal Infection Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Invasive Fungal Infection Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Invasive Fungal Infection Market Size Market Share by Application (2019-2024)
Table 10. Global Invasive Fungal Infection Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Invasive Fungal Infection Revenue Market Share by Player (2019-2024)
Table 12. Invasive Fungal Infection Key Players Head office and Products Offered
Table 13. Invasive Fungal Infection Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Invasive Fungal Infection Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Invasive Fungal Infection Market Size Market Share by Regions (2019-2024)
Table 18. Global Invasive Fungal Infection Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Invasive Fungal Infection Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Invasive Fungal Infection Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Invasive Fungal Infection Market Size Market Share by Country (2019-2024)
Table 22. Americas Invasive Fungal Infection Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Invasive Fungal Infection Market Size Market Share by Type (2019-2024)
Table 24. Americas Invasive Fungal Infection Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Invasive Fungal Infection Market Size Market Share by Application (2019-2024)
Table 26. APAC Invasive Fungal Infection Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Invasive Fungal Infection Market Size Market Share by Region (2019-2024)
Table 28. APAC Invasive Fungal Infection Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Invasive Fungal Infection Market Size Market Share by Type (2019-2024)
Table 30. APAC Invasive Fungal Infection Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Invasive Fungal Infection Market Size Market Share by Application (2019-2024)
Table 32. Europe Invasive Fungal Infection Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Invasive Fungal Infection Market Size Market Share by Country (2019-2024)
Table 34. Europe Invasive Fungal Infection Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Invasive Fungal Infection Market Size Market Share by Type (2019-2024)
Table 36. Europe Invasive Fungal Infection Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Invasive Fungal Infection Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Invasive Fungal Infection Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Invasive Fungal Infection Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Invasive Fungal Infection Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Invasive Fungal Infection Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Invasive Fungal Infection Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Invasive Fungal Infection Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Invasive Fungal Infection
Table 45. Key Market Challenges & Risks of Invasive Fungal Infection
Table 46. Key Industry Trends of Invasive Fungal Infection
Table 47. Global Invasive Fungal Infection Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Invasive Fungal Infection Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Invasive Fungal Infection Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Invasive Fungal Infection Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Cidara Therapeutics Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 52. Cidara Therapeutics Invasive Fungal Infection Product Offered
Table 53. Cidara Therapeutics Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Cidara Therapeutics Main Business
Table 55. Cidara Therapeutics Latest Developments
Table 56. Basilea Pharmaceutica Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 57. Basilea Pharmaceutica Invasive Fungal Infection Product Offered
Table 58. Basilea Pharmaceutica Main Business
Table 59. Basilea Pharmaceutica Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Basilea Pharmaceutica Latest Developments
Table 61. Pfizer Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 62. Pfizer Invasive Fungal Infection Product Offered
Table 63. Pfizer Main Business
Table 64. Pfizer Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Pfizer Latest Developments
Table 66. GlaxoSmithKline Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 67. GlaxoSmithKline Invasive Fungal Infection Product Offered
Table 68. GlaxoSmithKline Main Business
Table 69. GlaxoSmithKline Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. GlaxoSmithKline Latest Developments
Table 71. Bayer Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 72. Bayer Invasive Fungal Infection Product Offered
Table 73. Bayer Main Business
Table 74. Bayer Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Bayer Latest Developments
Table 76. Abbott Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 77. Abbott Invasive Fungal Infection Product Offered
Table 78. Abbott Main Business
Table 79. Abbott Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Abbott Latest Developments
Table 81. Merck Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 82. Merck Invasive Fungal Infection Product Offered
Table 83. Merck Main Business
Table 84. Merck Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Merck Latest Developments
Table 86. Astellas Pharma Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 87. Astellas Pharma Invasive Fungal Infection Product Offered
Table 88. Astellas Pharma Main Business
Table 89. Astellas Pharma Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Astellas Pharma Latest Developments
Table 91. F2G Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 92. F2G Invasive Fungal Infection Product Offered
Table 93. F2G Main Business
Table 94. F2G Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. F2G Latest Developments
Table 96. Scynexis Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 97. Scynexis Invasive Fungal Infection Product Offered
Table 98. Scynexis Main Business
Table 99. Scynexis Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Scynexis Latest Developments
Table 101. Associates of Cape Cod Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 102. Associates of Cape Cod Invasive Fungal Infection Product Offered
Table 103. Associates of Cape Cod Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Associates of Cape Cod Main Business
Table 105. Associates of Cape Cod Latest Developments
Table 106. BioRad Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 107. BioRad Invasive Fungal Infection Product Offered
Table 108. BioRad Main Business
Table 109. BioRad Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. BioRad Latest Developments
Table 111. IMMY Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 112. IMMY Invasive Fungal Infection Product Offered
Table 113. IMMY Main Business
Table 114. IMMY Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. IMMY Latest Developments
Table 116. Beijing Jinshanchuan Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 117. Beijing Jinshanchuan Invasive Fungal Infection Product Offered
Table 118. Beijing Jinshanchuan Main Business
Table 119. Beijing Jinshanchuan Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Beijing Jinshanchuan Latest Developments
Table 121. Danna Biological Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 122. Danna Biological Invasive Fungal Infection Product Offered
Table 123. Danna Biological Main Business
Table 124. Danna Biological Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Danna Biological Latest Developments
Table 126. Zhanjiang A and C Biological Details, Company Type, Invasive Fungal Infection Area Served and Its Competitors
Table 127. Zhanjiang A and C Biological Invasive Fungal Infection Product Offered
Table 128. Zhanjiang A and C Biological Main Business
Table 129. Zhanjiang A and C Biological Invasive Fungal Infection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 130. Zhanjiang A and C Biological Latest Developments
List of

Figure 1. Invasive Fungal Infection Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Invasive Fungal Infection Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Invasive Fungal Infection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Invasive Fungal Infection Sales Market Share by Country/Region (2023)
Figure 8. Invasive Fungal Infection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Invasive Fungal Infection Market Size Market Share by Type in 2023
Figure 10. Invasive Fungal Infection in Yeast-like Fungi
Figure 11. Global Invasive Fungal Infection Market: Yeast-like Fungi (2019-2024) & ($ Millions)
Figure 12. Invasive Fungal Infection in Filamentous Fungi
Figure 13. Global Invasive Fungal Infection Market: Filamentous Fungi (2019-2024) & ($ Millions)
Figure 14. Invasive Fungal Infection in Other
Figure 15. Global Invasive Fungal Infection Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Invasive Fungal Infection Market Size Market Share by Application in 2023
Figure 17. Global Invasive Fungal Infection Revenue Market Share by Player in 2023
Figure 18. Global Invasive Fungal Infection Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Invasive Fungal Infection Market Size 2019-2024 ($ Millions)
Figure 20. APAC Invasive Fungal Infection Market Size 2019-2024 ($ Millions)
Figure 21. Europe Invasive Fungal Infection Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Invasive Fungal Infection Market Size 2019-2024 ($ Millions)
Figure 23. Americas Invasive Fungal Infection Value Market Share by Country in 2023
Figure 24. United States Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Invasive Fungal Infection Market Size Market Share by Region in 2023
Figure 29. APAC Invasive Fungal Infection Market Size Market Share by Type in 2023
Figure 30. APAC Invasive Fungal Infection Market Size Market Share by Application in 2023
Figure 31. China Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Invasive Fungal Infection Market Size Market Share by Country in 2023
Figure 38. Europe Invasive Fungal Infection Market Size Market Share by Type (2019-2024)
Figure 39. Europe Invasive Fungal Infection Market Size Market Share by Application (2019-2024)
Figure 40. Germany Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Invasive Fungal Infection Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Invasive Fungal Infection Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Invasive Fungal Infection Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Invasive Fungal Infection Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 54. APAC Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 55. Europe Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 57. United States Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 58. Canada Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 61. China Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 62. Japan Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 63. Korea Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 65. India Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 66. Australia Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 67. Germany Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 68. France Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 69. UK Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 70. Italy Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 71. Russia Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 72. Spain Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 75. Israel Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Invasive Fungal Infection Market Size 2025-2030 ($ Millions)
Figure 78. Global Invasive Fungal Infection Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Invasive Fungal Infection Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted